Bookmark and Share
MAP kinase-activated protein kinase 2; MAPK-a.. [gi:1346538] - Target BioActivity Data
Also known as: MAP kinase-activated protein kinase 2; MAPK-activated protein kinase 2; MAPKAP kinase 2; MAPKAP-K2; MAPKAPK-2; MK-2; MK2.
Filters: All Data » Active      
Filter selected
BioActivity Outcomes:
Active(529)
 
 
BioAssay Types:
Literature(501)
 
 
BioActivity Types:
IC50(433)
 
 
EC50(78)
 
 
Ki(5)
 
 
Kd(4)
 
 
Substance Types:
Chemical(529)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 52    Data Row: 529   Total Pages: 11   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayLinks
OutcomeTypeValue [μM]
1
[SID134436469]
[CID56659490]
IC50 0.001Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay [AID604988, Type: Literature]
View
2
[SID134444187]
[CID56666415]
IC50 0.003Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis [AID604890, Type: Literature]
View
3
[SID134444188]
[CID56666416]
IC50 0.003Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis [AID604890, Type: Literature]
View
4
[SID134448078]
[CID56669831]
IC50 0.003Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis [AID604890, Type: Literature]
View
5
[SID134448079]
[CID56669832]
IC50 0.003Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis [AID604890, Type: Literature]
View
6
[SID134451969]
[CID56673316]
IC50 0.003Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis [AID604890, Type: Literature]
View
7
[SID134455766]
[CID56676654]
IC50 0.003Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis [AID604890, Type: Literature]
View
8
[SID134455767]
[CID56676655]
IC50 0.003Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis [AID604890, Type: Literature]
View
9
[SID134455768]
[CID56676656]
IC50 0.003Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis [AID604890, Type: Literature]
View
10
[SID134455771]
[CID42646706]
IC50 0.003Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis [AID604890, Type: Literature]
View
11
[SID104250105]
[CID42646698]
IC50 0.003Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis [AID604890, Type: Literature]
View
12
[SID134440359]
[CID56662943]
IC50 0.004Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis [AID604890, Type: Literature]
View
13
[SID103746415]
[CID25052767]
IC50 0.0043Inhibition of LPS-induced MK2 phosphorylation in human whole blood treated 30 mins before LPS challenge measured after 45 mins by FACS analysis [AID476158, Type: Literature]
View
14
[SID134440369]
[CID25066415]
IC50 0.005Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay [AID604988, Type: Literature]
View
15
[SID134444194]
[CID25066206]
IC50 0.005Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay [AID604988, Type: Literature]
View
16
[SID134436470]
[CID25065561]
IC50 0.005Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay [AID604988, Type: Literature]
View
17
[SID103746413]
[CID25118220]
IC50 0.0057Inhibition of LPS-induced MK2 phosphorylation in human whole blood treated 30 mins before LPS challenge measured after 45 mins by FACS analysis [AID476158, Type: Literature]
View
18
[SID134440360]
[CID56662944]
IC50 0.006Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis [AID604890, Type: Literature]
View
19
[SID134448080]
[CID56669833]
IC50 0.006Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis [AID604890, Type: Literature]
View
20
[SID134459604]
[CID56679979]
IC50 0.007Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis [AID604890, Type: Literature]
View
21
[SID103746495]
[CID25119291]
IC50 0.007Inhibition of LPS-induced MK2 phosphorylation in human whole blood treated 30 mins before LPS challenge measured after 45 mins by FACS analysis [AID476158, Type: Literature]
View
22
[SID103517311]
[CID10453611]
IC50 0.008Inhibition of MK2 [AID288456, Type: Literature]
View
23
[SID103517313]
[CID10007353]
IC50 0.008Inhibition of MK2 [AID288456, Type: Literature]
View
24
[SID134459543]
[CID25064743]
IC50 0.008Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay [AID604988, Type: Literature]
View
25
[SID134436452]
[CID56659478]
IC50 0.008Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis [AID604890, Type: Literature]
View
26
[SID136922829]
[CID57391324]
IC50 0.008Inhibition of human MK2 [AID640024, Type: Literature]
View
27
[SID136942353]
[CID56950243]
IC50 0.008Inhibition of human MK2 [AID640024, Type: Literature]
View
28
[SID103517294]
[CID10389239]
IC50 0.0085Inhibition of MK2 [AID288456, Type: Literature]
View
29
[SID103517294]
[CID10389239]
IC50 0.0085Inhibition of human recombinant MK2 expressed in Escherichia coli BL21(DE3) after 60 mins [AID390576, Type: Literature]
View
30
[SID136945508]
[CID57403552]
IC50 0.009Inhibition of human MK2 [AID640024, Type: Literature]
View
31
[SID136935985]
[CID57398376]
IC50 0.009Inhibition of human MK2 [AID640024, Type: Literature]
View
32
[SID136929273]
[CID57394816]
IC50 0.009Inhibition of human MK2 [AID640024, Type: Literature]
View
33
[SID134440290]
[CID25064093]
IC50 0.01Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay [AID604988, Type: Literature]
View
34
[SID134444116]
[CID25064744]
IC50 0.01Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay [AID604988, Type: Literature]
View
35
[SID134448093]
[CID25066412]
IC50 0.01Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay [AID604988, Type: Literature]
View
36
[SID123085245]
[CID25066416]
IC50 0.01Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis [AID604890, Type: Literature]
View
37
[SID103549701]
[CID23661566]
IC50 0.01Inhibition of MK2 after 30 mins by DELFIA [AID308554, Type: Literature]
View
38
[SID123085245]
[CID25066416]
IC50 0.012Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay [AID604988, Type: Literature]
View
39
[SID134436454]
[CID42646445]
IC50 0.012Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis [AID604890, Type: Literature]
View
40
[SID136932535]
[CID57396580]
IC50 0.012Inhibition of human MK2 [AID640024, Type: Literature]
View
41
[SID136935984]
[CID57398375]
IC50 0.012Inhibition of human MK2 [AID640024, Type: Literature]
View
42
[SID136942352]
[CID57401844]
IC50 0.012Inhibition of human MK2 [AID640024, Type: Literature]
View
43
[SID136942332]
[CID57401828]
IC50 0.012Inhibition of human MK2 [AID640024, Type: Literature]
View
44
[SID134436457]
[CID56659481]
IC50 0.013Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis [AID604890, Type: Literature]
View
45
[SID134448082]
[CID24748251]
IC50 0.014Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay [AID604988, Type: Literature]
View
46
[SID136935983]
[CID57398374]
IC50 0.014Inhibition of human MK2 [AID640024, Type: Literature]
View
47
[SID134440370]
[CID25066617]
IC50 0.015Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay [AID604988, Type: Literature]
View
48
[SID103517310]
[CID16720316]
IC50 0.015Inhibition of MK2 [AID288456, Type: Literature]
View
49
[SID134448092]
[CID25066411]
IC50 0.016Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assay [AID604988, Type: Literature]
View
50
[SID134451968]
[CID56673315]
IC50 0.017Inhibition of human MK2 using biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET analysis [AID604890, Type: Literature]
View